tiprankstipranks
Rakovina Therapeutics Inc (TSE:RKV)
:RKV
Canadian Market

Rakovina Therapeutics Inc (RKV) Financial Statements

Compare
12 Followers

Rakovina Therapeutics Inc Financial Overview

Rakovina Therapeutics Inc's market cap is currently C$16.66M. The company's EPS TTM is C$-0.044; its P/E ratio is ―; Rakovina Therapeutics Inc is scheduled to report earnings on April 25, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21
Income Statement
Total Revenue
Gross Profit---
Operating Income$ -2.48M$ -2.82M$ -2.47M
EBITDA$ -1.93M$ -2.26M$ -5.11M
Net Income$ -2.61M$ -2.79M$ -5.52M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―
Total Assets$ 5.15M$ 6.12M$ 8.66M
Total Debt$ 1.33M$ 0.00$ 0.00
Net Debt$ 896.78K$ -896.83K$ -2.81M
Total Liabilities$ 1.49M$ 107.05K$ 113.98K
Stockholders' Equity$ ―$ ―$ ―
Cash Flow
Free Cash Flow
Operating Cash Flow$ -1.86M$ -1.92M$ -2.31M
Investing Cash Flow
Financing Cash Flow
Currency in USD

Rakovina Therapeutics Inc Earnings and Revenue History

Rakovina Therapeutics Inc Debt to Assets

Rakovina Therapeutics Inc Cash Flow

Rakovina Therapeutics Inc Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis